(Q44556262)

4 December 2017

title

Leptin as an adjunct of insulin therapy in insulin-deficient diabetes (English)

1 reference

4 December 2017

1 reference

1 reference

F Miyanaga

1

1 reference

4 December 2017

Y Ogawa

2

1 reference

4 December 2017

K Ebihara

3

1 reference

4 December 2017

S Hidaka

4

1 reference

4 December 2017

T Tanaka

5

1 reference

4 December 2017

S Hayashi

6

1 reference

4 December 2017

H Masuzaki

7

1 reference

4 December 2017

K Nakao

8

1 reference

4 December 2017

publication date

20 August 2003

1 reference

4 December 2017

1 reference

4 December 2017

volume

46

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

1329-1337

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-003-1193-6

4 December 2017

exact match

0 references

cites work

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

12 December 2020

Metformin improved insulin resistance in type I, insulin-dependent, diabetic patients

1 reference

12 December 2020

Low plasma leptin levels contribute to diabetic hyperphagia in rats

1 reference

12 December 2020

Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy.

1 reference

12 December 2020

Changes in plasma leptin during the treatment of diabetic ketoacidosis

1 reference

12 December 2020

Positional cloning of the mouse obese gene and its human homologue

1 reference

12 December 2020

Central nervous system control of food intake

1 reference

12 December 2020

Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Unraveling the central nervous system pathways underlying responses to leptin

1 reference

12 December 2020

Increased glucose metabolism and insulin sensitivity in transgenic skinny mice overexpressing leptin.

1 reference

12 December 2020

Pathophysiological role of leptin in obesity-related hypertension.

1 reference

12 December 2020

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

12 December 2020

Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin

1 reference

12 December 2020

Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides.

1 reference

12 December 2020

Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats

1 reference

12 December 2020

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

1 reference

12 December 2020

Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects

1 reference

12 December 2020

Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.

1 reference

12 December 2020

Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Involvement of agouti-related protein, an endogenous antagonist of hypothalamic melanocortin receptor, in leptin action

1 reference

12 December 2020

Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression

1 reference

12 December 2020

Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action

1 reference

12 December 2020

Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.

1 reference

12 December 2020

Glucose metabolism and insulin sensitivity in transgenic mice overexpressing leptin with lethal yellow agouti mutation: usefulness of leptin for the treatment of obesity-associated diabetes.

1 reference

12 December 2020

Weight gain associated with intensive therapy in the diabetes control and complications trial. The DCCT Research Group

1 reference

12 December 2020

Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin

1 reference

12 December 2020

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

12 December 2020

Leptin-replacement therapy for lipodystrophy.

1 reference

12 December 2020

STZ-induced diabetes decreases and insulin normalizes POMC mRNA in arcuate nucleus and pituitary in rats.

1 reference

12 December 2020

Serum leptin levels in children and adolescents with insulin-dependent diabetes mellitus in relation to metabolic control and body mass index

1 reference

12 December 2020

Insulin requirement for the antihyperglycaemic effect of metformin

1 reference

12 December 2020

Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats

1 reference

12 December 2020

Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes.

1 reference

12 December 2020

Acute stimulation of glucose metabolism in mice by leptin treatment

1 reference

12 December 2020

Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.

1 reference

12 December 2020

Effect of a high-fat diet on food intake and hypothalamic neuropeptide gene expression in streptozotocin diabetes

1 reference

12 December 2020

10.1007/S00125-003-1193-6

Identifiers

DOI

1 reference

4 December 2017

1 reference